Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion
ADIA Nutrition Inc. (OTC Pink: ADIA) has launched a recruitment drive for sales representatives for its subsidiaries, Adia Med and Adia Labs. The initiative, announced on March 13, 2025, aims to expand the company's regenerative medicine and stem cell therapy presence nationwide.
Adia Med sales representatives will focus on establishing satellite locations by partnering with doctors, clinics, and medical spas, targeting regions with high demand for regenerative medicine. Meanwhile, Adia Labs representatives will promote 'Adia Vita,' a private-label umbilical cord stem cell product containing 100 million stem cells and 3 trillion exosomes per unit, for medical studies and research.
The company offers commission-based compensation and comprehensive training. Ideal candidates should possess strong communication skills, commitment to ethical practices, and knowledge or willingness to learn about regenerative medicine.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha avviato una campagna di reclutamento per rappresentanti di vendita per le sue filiali, Adia Med e Adia Labs. L'iniziativa, annunciata il 13 marzo 2025, mira ad espandere la presenza dell'azienda nella medicina rigenerativa e nella terapia con cellule staminali a livello nazionale.
I rappresentanti di vendita di Adia Med si concentreranno sull'istituzione di sedi satellite collaborando con medici, cliniche e centri benessere, puntando a regioni con alta domanda di medicina rigenerativa. Nel frattempo, i rappresentanti di Adia Labs promuoveranno 'Adia Vita', un prodotto di cellule staminali da cordone ombelicale a marchio privato contenente 100 milioni di cellule staminali e 3 trilioni di esosomi per unità, destinato a studi medici e ricerche.
L'azienda offre una compensazione basata sulle commissioni e una formazione completa. I candidati ideali dovrebbero possedere forti capacità comunicative, impegno verso pratiche etiche e conoscenza o disponibilità ad apprendere sulla medicina rigenerativa.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha lanzado una campaña de reclutamiento para representantes de ventas para sus subsidiarias, Adia Med y Adia Labs. La iniciativa, anunciada el 13 de marzo de 2025, tiene como objetivo expandir la presencia de la empresa en medicina regenerativa y terapia con células madre a nivel nacional.
Los representantes de ventas de Adia Med se enfocarán en establecer ubicaciones satélite colaborando con médicos, clínicas y spas médicos, apuntando a regiones con alta demanda de medicina regenerativa. Mientras tanto, los representantes de Adia Labs promoverán 'Adia Vita', un producto de células madre de cordón umbilical de marca privada que contiene 100 millones de células madre y 3 billones de exosomas por unidad, para estudios médicos e investigación.
La empresa ofrece compensación basada en comisiones y capacitación integral. Los candidatos ideales deben poseer fuertes habilidades de comunicación, compromiso con prácticas éticas y conocimiento o disposición para aprender sobre medicina regenerativa.
ADIA Nutrition Inc. (OTC Pink: ADIA)는 자회사인 Adia Med와 Adia Labs를 위한 판매 대표 모집 캠페인을 시작했습니다. 2025년 3월 13일에 발표된 이 이니셔티브는 전국적으로 회사의 재생 의학 및 줄기 세포 치료의 존재를 확대하는 것을 목표로 하고 있습니다.
Adia Med의 판매 대표는 의사, 클리닉 및 의료 스파와 협력하여 위성 위치를 설정하는 데 집중하며, 재생 의학에 대한 수요가 높은 지역을 목표로 합니다. 한편, Adia Labs의 대표는 의료 연구 및 연구를 위해 1억 개의 줄기 세포와 3조 개의 엑소좀을 포함하는 프라이빗 라벨 제대 줄기 세포 제품인 'Adia Vita'를 홍보할 것입니다.
회사는 커미션 기반 보상과 포괄적인 교육을 제공합니다. 이상적인 후보자는 강력한 의사소통 능력, 윤리적 관행에 대한 헌신, 재생 의학에 대한 지식 또는 배우려는 의지를 가져야 합니다.
ADIA Nutrition Inc. (OTC Pink: ADIA) a lancé une campagne de recrutement pour des représentants des ventes pour ses filiales, Adia Med et Adia Labs. L'initiative, annoncée le 13 mars 2025, vise à étendre la présence de l'entreprise dans la médecine régénérative et la thérapie par cellules souches à l'échelle nationale.
Les représentants des ventes d'Adia Med se concentreront sur l'établissement de sites satellites en s'associant avec des médecins, des cliniques et des spas médicaux, ciblant des régions à forte demande en médecine régénérative. Pendant ce temps, les représentants d'Adia Labs promouvoiront 'Adia Vita', un produit de cellules souches de cordon ombilical en marque blanche contenant 100 millions de cellules souches et 3 trillions d'exosomes par unité, pour des études médicales et de recherche.
L'entreprise propose une rémunération basée sur les commissions et une formation complète. Les candidats idéaux doivent posséder de solides compétences en communication, un engagement envers des pratiques éthiques et des connaissances ou une volonté d'apprendre sur la médecine régénérative.
ADIA Nutrition Inc. (OTC Pink: ADIA) hat eine Rekrutierungskampagne für Vertriebsmitarbeiter für seine Tochtergesellschaften Adia Med und Adia Labs gestartet. Die Initiative, die am 13. März 2025 angekündigt wurde, zielt darauf ab, die Präsenz des Unternehmens in der regenerativen Medizin und der Stammzelltherapie landesweit auszubauen.
Die Vertriebsmitarbeiter von Adia Med werden sich darauf konzentrieren, Satellitenstandorte zu etablieren, indem sie mit Ärzten, Kliniken und medizinischen Spas zusammenarbeiten und Regionen mit hoher Nachfrage nach regenerativer Medizin anvisieren. In der Zwischenzeit werden die Vertreter von Adia Labs 'Adia Vita' bewerben, ein Produkt mit privaten Label von Nabelschnur-Stammzellen, das 100 Millionen Stammzellen und 3 Billionen Exosomen pro Einheit enthält, für medizinische Studien und Forschungen.
Das Unternehmen bietet eine provisionsbasierte Vergütung und umfassende Schulungen an. Ideale Kandidaten sollten über starke Kommunikationsfähigkeiten, Engagement für ethische Praktiken und Wissen oder die Bereitschaft verfügen, über regenerative Medizin zu lernen.
- Expansion initiative through nationwide recruitment of sales force
- Strategic focus on high-demand markets for regenerative medicine
- Innovative product offering with Adia Vita containing significant stem cell count
- Commission-based compensation structure indicates variable income potential
- Success dependent on building new partnerships and market penetration
Unleashing the Future of Stem Cell Therapy and Regenerative Medicine Across the U.S.
Winter Park, Florida--(Newsfile Corp. - March 13, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in health, wellness, and regenerative medicine, is thrilled to announce it is recruiting dynamic sales representatives for its subsidiaries, Adia Med and Adia Labs, with job postings now live on Indeed. This bold initiative, a key part of ADIA Nutrition's roadmap for success and profitability, will propel the company's mission to deliver cutting-edge stem cell therapies and regenerative solutions to doctors, clinics, and medical spas nationwide by securing top-tier sales talent.
Adia Med Sales Representatives
Adia Nutrition is seeking motivated sales professionals to join Adia Med, tasked with partnering with doctors, clinics, and leading medical spas to establish Adia Med satellite locations. These reps will research target demographics and high-opportunity regions, pinpointing cities with strong demand for regenerative medicine. Within their region, they'll collaborate with top med spas, physicians, and clinics to structure deals that integrate Adia Med's innovative therapies, enhancing patient care and broadening the subsidiary's national presence.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/243941_adia_med_sales_indeed.jpg
Ideal candidates for Adia Med sales representatives should possess strong communication and networking skills, a commitment to ethical practices in sales, and an understanding-or willingness to learn-about regenerative medicine and stem cell therapies.
Adia Labs Sales Representatives
At the same time, Adia Nutrition is building an exceptional sales team for Adia Labs to promote its flagship stem cell product, "Adia Vita." These representatives will connect with doctors and clinics within their region, offering Adia Vita-a private-label umbilical cord stem cell product packed with 100 million stem cells and 3 trillion exosomes per unit-for studies, trials, and research. This team will drive Adia Labs' efforts to push the boundaries of medical science.
"We're looking for a passionate, skilled sales force to take our vision nationwide," said Larry Powalisz, CEO of Adia Nutrition. "We aim to empower our sales team with the knowledge and tools to make a real difference in people's lives. This isn't just a sales job; it's a chance to be part of a movement toward more effective, patient-centered healthcare."
Ideal candidates for Adia Labs sales reps should bring a background in medical or health-related sales, strong communication and networking skills, a commitment to ethical practices in healthcare sales, and an understanding-or eagerness to learn-about regenerative medicine and stem cell therapies.
Adia Nutrition offers commission-based compensation, comprehensive training, and the opportunity to lead the charge in an expanding field of medicine.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/243941_adia_labs_sales_rep_indeed.jpg
To Apply, visit https://www.indeed.com/cmp/Adia-Nutrition/jobs or you can contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243941
FAQ
What is Adia Nutrition's (ADIA) new sales recruitment initiative about?
What are the specifications of ADIA's stem cell product Adia Vita?
What are the key responsibilities for Adia Med sales representatives?
What compensation does ADIA offer to its sales representatives?
